1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medacta Group SA
  6. News
  7. Summary
    MOVE   CH0468525222

MEDACTA GROUP SA

(MOVE)
  Report
Delayed Swiss Exchange  -  11:30 2022-07-01 am EDT
91.40 CHF   +0.33%
06/23Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical Platform in Australia
EQ
05/24MEDACTA : Company Presentation
PU
05/19Medacta Group announces the results of today's Annual General Meeting
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medacta FY21 Revenue Up 20% on Carryover, Customer Acquisition

01/20/2022 | 01:30am EDT


© MT Newswires 2022
All news about MEDACTA GROUP SA
06/23Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical ..
EQ
05/24MEDACTA : Company Presentation
PU
05/19Medacta Group announces the results of today's Annual General Meeting
EQ
05/19Medacta Group SA Approves Distribution
CI
05/19Orthopedic Products Group Medacta Inaugurates New Offices In Switzerland
MT
05/18Medacta opens new offices in Rancate, Switzerland
EQ
05/18Medacta Group SA Opens New Offices in Rancate, Switzerland
CI
04/25Medacta's NextAR Spine Program Used in Lumbar Fusion Procedure in US
MT
04/25MEDACTA : Announces First Lumbar Fusion Procedure with NextAR Spine Augmented Reality Surg..
PU
04/25Medacta Announces First Lumbar Fusion Procedure with NextAR Spine Augmented Reality Sur..
EQ
More news
Analyst Recommendations on MEDACTA GROUP SA
More recommendations
Financials
Sales 2022 418 M 435 M 435 M
Net income 2022 61,1 M 63,6 M 63,6 M
Net Debt 2022 107 M 111 M 111 M
P/E ratio 2022 29,0x
Yield 2022 0,73%
Capitalization 1 825 M 1 898 M 1 898 M
EV / Sales 2022 4,62x
EV / Sales 2023 4,03x
Nbr of Employees 1 341
Free-Float 30,4%
Chart MEDACTA GROUP SA
Duration : Period :
Medacta Group SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDACTA GROUP SA
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 91,28 €
Average target price 124,39 €
Spread / Average Target 36,3%
EPS Revisions
Managers and Directors
Francesco Siccardi Chief Executive Officer
Corrado Farsetta Chief Financial Officer
Alberto Siccardi Non-Executive Chairman
Victor Waldemar Balli Lead Independent Non-Executive Director
Philippe A. Weber Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MEDACTA GROUP SA-35.63%1 898
ABBOTT LABORATORIES-21.69%192 989
MEDTRONIC PLC-11.67%121 417
BECTON, DICKINSON AND COMPANY2.45%71 779
BAXTER INTERNATIONAL INC.-23.71%32 976
HOYA CORPORATION-32.14%31 045